Clinical Trial Update: Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 [Phase 1]

View source ↗

Summary

Phase 1 study of a topical GW786034 for chronic plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• GW786034

Snippet

Sponsor: GlaxoSmithKline | Conditions: Psoriasis | Phase 1 | Status: COMPLETED